• Site Solutions Summit 2012: New Trade Association Grabs Spotlight

    Oct 30 | eCliniqua | The recently held annual Site Solutions Summit* was a high energy gathering of 500 clinical trial professionals culminating with a big announcement—the formation of the Society for Clinical Research Sites (SCRS). This new trade association is intended to provide a much-needed collective voice and a community for global investigative sites, which are anxious for a place at the table as the clinical trials industry works to improve operational efficiency.

    Oct 30, 2012

  • Four Ways an Integrated EDC/EHR Platform Can Boost Your R&D Efforts

    Oct 29 | eClin | Vendor Contributed Comment | 2012 has been a bumpy ride for pharmaceutical firms, exacerbated by a significant loss of revenue related to drug patent expirations. It’s been estimated that drugs scheduled to go off patent this year represent over $30 billion in sales. A wealth of new tools and technological advancements may be the answer for how researchers can discover new, life-saving therapies more quickly while simultaneously cutting costs. One development that is generating a lot of industry buzz is the integration of electronic data capture (EDC) platforms, traditionally used to manage clinical trials, with those used within the health care industry to create and maintain electronic health records (EHR).   

    Oct 26, 2012

  • MMG, Remedy Health Media Partner on Patient Recruitment

    Oct 17 | News Brief | MMG, a clinical trial patient recruitment firm, and Remedy Health Media are partnering to deliver unique access to a larger pool of qualified potential clinical trial participants.

    Oct 17, 2012

  • BioClinica Expands Imaging Services

    Oct 16 | News Brief |  BioClinica has announced the immediate availability of new and expanded imaging services critical for clinical trials in the area of osteoarthritis.

    Oct 16, 2012

  • Clinical Trials Influencing Investors

    Oct 16 | Seeking Alpha | Do clinical trial results sway biotech investors? Investors may be able to determine FDA approvals from trials, but then again they may not.

    Oct 16, 2012

  • Nextrials, InClin Sign Partnership

    Oct 8 | News Brief | Nextrials and InClin sign partnership to link Prism to CRO services.

    Oct 15, 2012

  • Sanofi, Massachusetts General Hospital, Sign Trans Med Agreement

    Oct 9, 2012 | News Brief | Sanofi has announced a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors.

    Oct 15, 2012

  • DATATRAK Signs Imaging CRO Partner

    Oct 9 | News Brief |  DATATRAK International has announced that ABX-CRO, a company providing global molecular and advanced imaging services for oncology and neuroscience to the pharmaceutical and biotechnology industries, is its first imaging partner.

    Oct 15, 2012

  • Consultant: Life Science Vendors Need a New Game Plan

    Oct 15 | eCliniqua | Life science vendors must become more strategic and price-sensitive to “stay in the game” with their clients in the trillion-dollar drug development industry, says Andreas Scherer, managing partner at consulting firm Salto Partners. The industry consensus is that drug research takes too long and has grown unsustainably expensive.

    Oct 15, 2012

  • WCC Announces Endpoint Assessment Committee

    Oct 1 | News Brief | WorldCare Clinical (WCC) has announced its new Endpoint Assessment Committee (EAC) services for blinded independent central review of clinical trial data. WCC’s EAC services include expert assessments by physicians drawn from multiple therapeutic areas for comprehensive efficacy and safety reviews.

    Oct 1, 2012

  • Medidata Uses Open Chef for Clinical Development in the Cloud

    Sep 24 | eCliniqua | Medidata Solutions has deployed Opscode Hosted Chef to automate its hybrid infrastructure for clinical development: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, to clinical data capture and management, safety events capture, medical coding, and business analytics. 

    Sep 24, 2012

  • Sanofi Uses BioClinica's CTMS

    Sep 24 | News Brief | Sanofi has selected BioClinica's OnPoint as the company's standard CTMS (Clinical Trial Management System). With this decision, Sanofi plans to utilize OnPoint CTMS for all clinical trial management activity. 

    Sep 24, 2012

  • Phase II Flub for Peregrine

    Sep 24 | Cancer Grace | A week after releasing favorable Phase II results for the novel vascular-targeting immunotherapy for non-small cell lung cancer, bavituximab, study sponsor Peregrine Pharmaceuticals has announced "major discrepancies" in the trial.

    Sep 24, 2012

  • Why You Should Be Adopting Adaptive Trials

    Sep 20 | eCliniqua | A special one-day conference next month will showcase many of the leading figures in the emerging field of adaptive trial designs, with a view to helping organizations recognize their benefits and understand the keys to successful implementation.

    Sep 20, 2012

  • Updated EDC for Any Research Initiative

    Sep 17 | Product Brief | The latest version of iMedNet EDC was announced today. iMedNet EDC makes electronic data capture functionality practical for any type of research initiative, even very small studies of short duration. 

    Sep 17, 2012

  • Mathieu Takeaways on the 2012 Clinical Trial Sourcebook

    Sep 17 | eCliniqua | Mark Mathieu—director of Strategic Research at PAREXEL Consulting—is the founding editor of the PAREXEL Biopharmaceutical R&D Statistical Sourcebook. As such, he is the ideal person to discuss the highlights and nuances that emerge in the latest edition of the sourcebook (2012-13). Mathieu recently spoke to Barnett International’s Rachel Meyers.

    Sep 12, 2012

  • Boehringer Ingelheim to Launch Pharma Facebook Game

    PSFK | Boehringer Ingelheim has developed a Facebook game called Syrum. The health of the world is in the user's hands, and players can collaborate with others to save it. 

    Sep 13, 2012

  • Isis Tightens Bond to BioClinica

    Sep 13 | eCliniqua Exclusive | EDC purist Isis Pharmaceuticals is stepping up its partnering activity with BioClinica, Inc. to include larger and more complex clinical trials within its expansive antisense drug development program. Up to 20 new trials are on the docket for next year, including several phase III studies involving thousands of participants.  

    Sep 12, 2012

  • CDISC and C-Path Launch Coalition for Accelerating Standards Therapies

    Sep 12 | CDISC | The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) have announced the launch of the Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year.

    Sep 12, 2012

  • Informed Consent: There's an App for That

    Sept 12 | PharmaTimes | Mytrus has launched an iPad app explaining the informed consent process.

    Sep 12, 2012